Unicycive Therapeutics Shares Are Trading Higher After Piper Sandler Initiated Coverage on the Stock With an Overweight Rating and a Price Target of $9
派珀·桑德勒開始對Unicycive Therapeutics進行增持評級,目標股價爲9美元,此後,Unicycive Therapeutics的股價走高
Unicycive Therapeutics Shares Are Trading Higher After Piper Sandler Initiated Coverage on the Stock With an Overweight Rating and a Price Target of $9
派珀·桑德勒開始對Unicycive Therapeutics進行增持評級,目標股價爲9美元,此後,Unicycive Therapeutics的股價走高
使用瀏覽器的分享功能,分享給你的好友吧